Introduction c-Myc participates in the control of cellular proliferation, programmed cell death, and dierentiation (Amati et al., 1998; Henriksson and Luscher, 1996; Packham and Cleveland, 1995) . c-Myc belongs to a small family of transcription factors that contain basic, helix ± loop ± helix and leucine zipper domains (Blackwell et al., 1990; Murre et al., 1989; Prendergast and Zi, 1989) . c-Myc displays sequence-speci®c DNA-binding properties only when bound to Max, its heterodimeric partner (Blackwood and Eisenman, 1991; Kato et al., 1992) . The interaction with Max has been shown to be necessary for most of the physiological eects of c-Myc, including promotion of cell growth and apoptosis (Amati et al., 1993a,b) . c-Myc has been implicated in both the activation and repression of transcription (Amati et al., 1992; Inghirami et al., 1990; Kretzner et al., 1992; Penn et al., 1990; Yang et al., 1991) . The role of the Myc ± Max heterodimer in repression is unclear (Lee et al., 1997; Marhin et al., 1997; Penn et al., 1990) .
The expression of the c-myc gene is closely correlated with proliferation. c-myc expression is absent in quiescent cells but is rapidly induced upon the addition of growth factors (Cole, 1986; Dean et al., 1986; Spencer and Groudine, 1991; Waters et al., 1991) . c-Myc levels peak approximately 2 ± 4 h after serum stimulation and are subsequently reduced to a low constitutive level throughout the remainder of the cell cycle (Persson et al., 1985; Rabbitts et al., 1985) . Removal of growth factors at any point in the cell cycle results in the prompt down regulation of c-Myc expression (Dean et al., 1986; Waters et al., 1991) . Ectopic expression in quiescent cells, under some conditions, can elicit entry into S phase (Eilers et al., 1991; Kaczmarek et al., 1985; Steiner et al., 1995) , while overexpression of c-Myc in growing cells leads to reduced growth requirements and a shortened G1 phase (Karn et al., 1989) . In contrast, reduction of cmyc expression by antisense methods, or deletion of the gene by homologous recombination, lead to a lengthening of the cell cycle (Heikkila et al., 1987; Holt et al., 1988; Mateyak et al., 1997) . c-myc null cells display a lengthening of both the G1 and G2 phases of the cell cycle, while S phase duration remains unchanged (Mateyak et al., 1997) . The focus of this review will be the role of c-Myc in promoting the G0 to G1 and G1 to S phase transitions.
The cell cycle machine
The eukaryotic cell cycle is regulated by the coordinated action of cyclins and cyclin-dependent kinases (Cdks). The initial transition from G0 to G1 phase and the subsequent transition from G1 to S phase are mediated by a series of sequential regulatory events (Figure 1 ). D-type cyclins are the ®rst group of cyclins to be synthesized and their expression is closely coupled to the action of growth factors (Matsushime et al., 1991; Sherr, 1995; Won et al., 1992) . D-type cyclins bind and activate Cdk4 and Cdk6 (Bates et al., 1994; Matsushime et al., 1992; Meyerson and Harlow, 1994) . The major targets of the cyclin D/Cdk4 and cyclin D/ Cdk6 complexes are the retinoblastoma protein (Rb) and the related proteins p107 and p130 (Beijersbergen and Bernards, 1996; Beijersbergen et al., 1995; Xiao et al., 1996) . Phosphorylation of Rb in mid-G1 leads to the release of active forms of the E2F family of transcription factors (Chellappan et al., 1991; Dynlacht et al., 1994; Hiebert et al., 1992) . Targets of E2F identi®ed to date include cyclin E, cyclin A and many S phase-speci®c genes such as thymidine kinase and polymerase a (Botz et al., 1996; Dou et al., 1994; Lee et al., 1995; Polyak et al., 1994a,b; Xiong et al., 1993) . The second group of inhibitors, known as the INK family, consists of the p15, p16, p18, and p19 proteins. Unlike the Cip/Kip family, these inhibitors are only active on Cdk4/6 containing complexes. In addition, binding of the INK proteins to Cdk4/6 is independent of cyclins (Chan et al., 1995; Guan et al., 1994; Hannon and Beach, 1994; Hirai et al., 1995; Serrano et al., 1993) . Members of both families of inhibitors have been shown to be important for executing growth arrest signals in response to a variety of signals, such as DNA damage, senescence, contact inhibition, and TGF-b treatment (Sherr and Roberts, 1995) . Phosphorylation, both inhibitory and activating, represents another major mode of Cdk regulation. Activating phosphates are added to T172 on Cdk4 and T160 on Cdk2 by the Cdk-activating kinase (CAK) (Gu et al., 1992; Kato et al., 1994) . Inhibitory phosphates are removed from Y17 on Cdk4, and T14 and Y15 on Cdk2 by a family of phosphatases known as Cdc25 proteins (Honda et al., 1993; Sebastian et al., 1993; Terada et al., 1995) .
The early steps
Perhaps the most compelling manner in which c-Myc could in¯uence cell cycle progression would be by regulating the expression of cyclin genes. Since c-Myc expression precedes that of the D-type cyclins during the G0 to S transition, it was tempting to speculate that the cyclin D gene may be regulated by c-Myc. Initial studies employing a chimeric Myc-ER protein reported both transactivation and repression of cyclin D1 expression (Daksis et al., 1994; Jansen-Durr et al., 1993; Philipp et al., 1994) . Myc-ER is a fusion of the cMyc coding region to the regulatory domain of the estrogen receptor; Myc-speci®c activity of the hybrid protein can be activated by the addition of estrogen or estrogen analogs to the medium (Eilers et al., 1989) . Subsequent studies have shown, however, that the initial observation of cyclin D1 gene activation may have been compromised by the presence of a cryptic, estrogen-activatable transactivation domain in the estrogen receptor moiety of the Myc-ER fusion protein (Solomon et al., 1995) . The second generation version of Myc-ER (Myc-ER TM ) thus lacks this Figure 1 The cyclin/Cdk machine of the G0 to S transition. Post-translational regulation is shown with black arrows (activating events) or black bars (inhibitory events). Transcriptional activation is shown with red arrows. Inhibitory and activating phosphorylations are shown as`P' in a magenta or green ®eld, respectively. Cdk4 and 6 lack the inhibitory phosphorylation site homologous to Thr14 in Cdk2, but retain the site homologous to Tyr15 (Tyr17 in Cdk4). The kinase that phosphorylates Tyr17 in Cdk4 has not been identi®ed. The`?' symbols refer to the uncertainty concerning the regulation of cyclin D gene expression, and the substrates of cyclin E/Cdk2 complexes, other than Rb, that are required for entry into S phase. Abbreviations: D, cyclin D; K4/6, Cdk4 and Cdk6; E, cyclin E; K2, Cdk2; INK4, INK4 family of CKI proteins (p15, p16, p18, p19); p21, CIP1/WAF1; p27, KIP1 transactivation domain and is only responsive to the estrogen analog 4-hydroxytamoxifen (Danielian et al., 1993; Littlewood et al., 1995) .
The mechanism of c-Myc-mediated repression of the cyclin D1 gene has been proposed to involve the interaction of c-Myc with a novel partner, Miz-1 (Peukert et al., 1997) . Miz-1, which is also a transcription factor, upregulates cyclin D1 as well as several genes that cause cell cycle arrest. Interaction of c-Myc with Miz-1 has been proposed to inhibit the transactivation activity of Miz-1, allowing cells to cycle and, paradoxically, downregulating the expression of cyclin D1.
Most recent studies of the in¯uence of c-Myc on cyclin D expression utilized a c-myc7/7 cell line created by gene targeting (Mateyak et al., 1997) . In the complete absence of c-Myc, cyclin D1 mRNA expression was very slightly reduced (M Mateyak and J Sedivy, unpublished results). Thus, in spite of some confusion in the past, it now appears that c-Myc has a marginal, if any, eect on cyclin D1 gene expression.
In addition to the transcriptional regulation of cyclin D1, c-Myc has also been implicated in aecting its translation by regulating the expression of the eIF-4E gene (Rosenwald et al., 1993a) . In these experiments, activation of Myc-ER was observed to elicit an increase in cyclin D1 protein expression. This was shown to be due to an increase in the association of cyclin D1 mRNA with polysomes and this increase closely followed eIF-4E induction (Rosenwald et al., 1995) . However, expression of the eIF-4E gene is not altered in c-myc null ®broblasts (Bush et al., 1998) , therefore the proposed role of c-Myc and eIF-4E in the post transcriptional regulation of cyclin D1 requires further examination.
An intriguing interdependence between c-Myc and cyclin D1 expression has been observed . Cells expressing a mutant form of the colonystimulating factor receptor (CSF-1R Y809F) do not enter S phase in response to CSF. However, expression of c-Myc or cyclin D1, but not cyclin E, restores cell cycle entry. The expression of c-Myc triggers upregulation of cyclin D1 mRNA and protein and vice versa. The induction of c-myc by cyclin D1 requires the Rb-binding domain of cyclin D1. This suggests that c-Myc upregulation occurs through the E2F-Rb pathway and the action of the E2F transcription factors on the c-myc promoter (Oswald et al., 1994) . The mechanisms through which c-Myc may upregulate the levels of cyclin D1 mRNA were not investigated in these experiments.
A role for c-Myc in regulating cyclin D1/Cdk4 complex activity must also be considered. Following the activation of Myc-ER in quiescent cells, preexisting cyclin D1/Cdk4 complexes are activated (Steiner et al., 1995) . It is dicult to make any conclusions about this observation, however, since cyclin D1/Cdk4 activation in these experiments occurred subsequent to the activation of cyclin E/Cdk2 complexes (Steiner et al., 1995) , and both complexes seemed to be deregulated in the presence of active Myc-ER (Pusch et al., 1997; Steiner et al., 1995) . A link between c-Myc and cyclin D1/Cdk4 activity is also suggested by experiments in which the co-transformation by Ras and c-Myc (or cyclin E) required cyclin D1/Cdk4 activity (Haas et al., 1997a,b) . In summary, the evidence for a link between c-Myc and cyclin D1/Cdk4 activity remains circumstantial, and more work needs to be done to identify a role for c-Myc, if any, in the activation of these complexes.
Is c-Myc the key to the activation of cyclin E/Cdk2 complexes?
Cyclin E expression directly precedes the transition from G1 to S phase, but considerable levels of cyclin E protein have also been detected in resting cells. Despite the presence of basal levels of cyclin E/Cdk2 complexes in quiescent cells, these complexes remain inactive (Steiner et al., 1995) . Several studies employing various approaches have shown that c-Myc participates in the activation of cyclin E/Cdk2 complexes at the G1/S boundary (Berns et al., 1997; MuÈ ller et al., 1997; PeÂ rezRoger et al., 1997; Steiner et al., 1995; Vlach et al., 1996) . Activation of Myc-ER in quiescent cells resulted in a rapid activation of cyclin E/Cdk2 kinase activity (Steiner et al., 1995) . Similarly, activation of Myc-ER in exponentially growing cells separated by centrifugal elutriation caused activation of cyclin E/Cdk2 at early times in G1 (Pusch et al., 1997) . Finally, Vlach et al. (1996) observed that overexpression of c-Myc can overcome a p27-imposed cell cycle arrest. p27 causes G1 arrest at least in part by inhibiting cyclin E/Cdk2 activity, and the presence of c-Myc allowed these complexes to remain active despite the presence of increased levels of p27. Two mechanisms have been proposed to explain the observed aects of c-Myc on cyclin E/Cdk2 activity (Figure 2) . These mechanisms will be described separately, but it should be noted that they are not mutually exclusive and may perhaps prove to be complementary.
The ®rst mechanism was postulated by Vlach et al. (1996) who suggested that expression of c-Myc induces the expression of a p27-sequestering protein. This hypothesis came from several observations. First, activation of Myc-ER in quiescent cells led to a conversion of cyclin-containing complexes from a higher molecular weight form to a lower molecular weight form. This reorganization was shown to be due to the loss of p27 from the cyclin E/Cdk2 complexes (Steiner et al., 1995) . Second, boiled extracts from cells overexpressing both c-Myc and p27 could still inhibit exogenously added cyclin E/Cdk2 complexes (Vlach et al., 1996) . This result was explained by proposing that the boiled extracts contained active p27 protein, which retained its inhibitory function, but that the c-Myc induced p27-sequestering protein had been inactivated. However, the putative c-Myc-regulated p27-sequestering protein has not been identi®ed to date.
The elimination of p27 from cyclin E/Cdk2 complexes does not require its degradation. p27 is degraded by the ubiquitin pathway; its half-life is higher in contact-inhibited cells and decreases as cells enter S phase (Hengs and Reed, 1994; Pagano et al., 1995) . Although upon expression of ectopic c-Myc p27 is lost from cyclin E/Cdk2 complexes, it has been shown that the c-Myc-dependent activation of these complexes is not blocked by the presence of proteosome pathway inhibitors. This observation argues against a direct involvement of c-Myc in p27 degradation (MuÈ ller et al., 1997; Vlach et al., 1996) . It is however interesting to note that phosphorylation of p27 by cyclin E/Cdk2 complexes is required for its degradation (MuÈ ller et al., 1997; Shea et al., 1997; Vlach et al., 1997) .
If the downstream target of c-Myc is in fact the cyclin E/Cdk2 complex, it can be argued that the presence of excess cyclin E could titrate excess p27 and subsequently activate at least a fraction of the complexes. In the experiments described by Vlach et al. (1996) overexpression of cyclin E did not rescue the cell cycle arrest caused by p27. This result was interpreted as an indication that in the absence of cMyc-induced upregulation of the putative p27-sequestering protein, p27 levels must have been high enough to inhibit even the additional cyclin E/Cdk2 complexes recruited by the exogenously expressed cyclin E. In contrast, Shea et al. (1997) have found that overexpression of cyclin E could rescue a p27-imposed cell cycle arrest.
It has been shown that overexpression of cyclin E is able to accelerate S phase entry (Resnitzy et al., 1994) and to induce S phase entry without the activation of the pRb/E2F pathway (Lukas et al., 1997) . Therefore, it makes sense that the cell would wish to tightly regulate the activation of cyclin E/Cdk2 complexes in order to avoid any undesirable S phase entry. Clearly, the manner in which S phase entry depends on the relative levels of cyclin E and p27 expression and the perturbations that can override a p27-imposed G1 arrest need continued investigation.
The second mechanism proposes that the ability of c-Myc to increase the level of cyclin E expression is key to the activation of cyclin E/Cdk2 complexes. The authors propose that c-Myc expression results in the increased formation of new cyclin E/Cdk2 complexes, and may also act to block p27 from associating with the newly formed complexes (PeÂ rez-Roger et al., 1997). These p27-free complexes would then phosphorylate p27 in the resident cyclin E/Cdk2 complexes, forcing p27 release, and resulting in a feedback mechanism leading to the full activation of all complexes (PeÂ rez-Roger et al., 1997). It has been observed by several groups that upon Myc-ER activation, cyclin E mRNA levels increase approximately 2.5-fold, and it is this newly synthesized cyclin E that would participate in the assembly of new, p27-free complexes (Jansen-Durr et al., 1993; PeÂ rez-Roger et al., 1997; Steiner et al., 1995) . The manner in which c-Myc would prevent the association of p27 with newly formed cyclin E/Cdk2 complexes has not been explained (PeÂ rez-Roger et al., 1997). MuÈ ller et al. (1997) also observed an increase in cyclin E expression upon Myc-ER induction, however, based on their observation that p27-bound cyclin E/Cdk2 complexes can still phosphorylate p27, they downplayed the importance of the newly synthesized complexes. It is interesting to note that the activation of cyclin E transcription in response to Myc-ER activation occurred in the presence of cyclohexamide, suggesting that c-Myc plays a direct role (PeÂ rez-Roger et al., 1997). However, the cyclin E promoter does not contain any consensus c-Myc binding sites; therefore, the mechanism by which c-Myc regulates cyclin E gene expression is unknown. In addition, the model of PeÂ rez-Roger et al. (1997) does not speci®cally rule out a role for a p27-sequestering protein. Figure 2 Proposed mechanisms for the regulation of cyclin E/Cdk2 activity by c-Myc. c-Myc has been implicated in the transcriptional upregulation of the cyclin E gene, in preventing the association of p27 with newly formed cyclin E/Cdk2 complexes, and in the transcriptional upregulation of a putative p27-sequestering protein. Whether p27 in cyclin E/Cdk2/p27 complexes is phosphorylated in an intramolecular reaction or in an intermolecular reaction by p27-free cyclin E/Cdk2 complexes has not been resolved. Please refer to Figure 1 for symbol designations. SP, putative p27-sequestering protein Recent work demonstrates the intricate nature of the interaction between p27 and cyclin E/Cdk2 complexes. Mutants of p27 lacking either cyclin-or Cdkinteracting domains were not able to cause G1 arrest in Rat-1 cells, although they were able to bind cyclin E/Cdk2 complexes . In addition, a p27 mutant defective in Cdk binding (p27 k7 ) associated with active cyclin E/Cdk2 complexes, and was phosphorylated and targeted for degradation at a higher rate than the wild-type p27 protein . Therefore, it appears that p27 must bind to both the cyclin and Cdk subunits of the cyclin E/Cdk2 complex in order to cause cell cycle arrest and to avoid being targeted for degradation. It is interesting that phosphorylation of p27 also aects its binding anity for cyclin E/Cdk2 complexes, and facilitates its release (MuÈ ller et al., 1997) .
It is not yet clear how phosphorylation aects the interaction of p27 with the active site of Cdk2 since the carboxy-terminal domain of p27 is absent from the currently available cyclin A/Cdk2/p27 crystal structure (Russo et al., 1996) . If it is shown that the phosphorylated form of p27 is not able to inhibit cyclin E/Cdk2 complexes, then the requirement for cMyc to activate these complexes would be upstream of phosphorylation and subsequent dissociation and degradation. In summary, c-Myc has been implicated in the induction of cyclin E mRNA synthesis, in blocking the binding of p27 to newly formed cyclin E/ Cdk2 complexes, and in sequestering p27 from the existing cyclin E/Cdk2 complexes. Future work will have to determine the precise role of each of these mechanisms in the activation of cyclin E/Cdk2 complexes by c-Myc.
The role of cyclin D complexes in cyclin E/Cdk2 activation
Overexpression of cyclin E requires the presence of cMyc or growth factors in order to cause cells to enter S phase (PeÂ rez-Roger et al., 1997; Roussel et al., 1995) . This implies a requirement for a c-Myc mediated function prior to the activation of cyclin E/Cdk2. Cyclin D/Cdk4 complexes are formed and activated before the onset of cyclin E/Cdk2 activity, and evidence has been presented that these complexes and/or their activity is necessary for orderly transition to S phase. Microinjection of antibodies against cyclin D1 inhibited cell cycle progression in response to growth factors (Baldin et al., 1993; Quelle et al., 1993) or in response to Myc-ER activation (Steiner et al., 1995) . In the absence of growth factors, MEK1 activation in cells overexpressing cyclin D1 does not cause cyclin E/Cdk2 activation. However, co-expression of cyclin D1 and Cdk4 together with active MEK1 is able to activate cyclin E/Cdk2 complexes even in the absence of p27 degradation (Cheng et al., 1998) . Similarly, expression of cyclin D1 and Cdk4 overrides the cell cycle arrest imposed by p27 overexpression. However, in contrast to what happens in cells overexpressing cyclin E, the overall levels of p27 protein do not decline during S phase entry triggered by cyclin D1/Cdk4 overexpression (Shea et al., 1997) . Therefore, it is tempting to speculate that cyclin D1/ Cdk4 complexes might titrate p27 away from cyclin E/ Cdk2 complexes, allowing these complexes to become active (Sherr and Roberts, 1995) .
c-Myc and the INK/Rb pathway
Does c-Myc play a role in regulating the p16/Rb pathway? In proliferating cells, c-Myc expression is able to promote growth in the presence of p16 overexpression; however, it should be noted that activation of Myc-ER in quiescent cells is not sucient to override a G1 arrest imposed by p16 (Alevizopoulos et al., 1997; Rudolph et al., 1996) . Besides c-Myc overexpression, cyclin E overexpression but not that of any other cyclin, can promote S phase entry under these conditions (Alevizopoulos et al., 1997) . INK proteins bind only the Cdk4/6 proteins, and thus inhibit cyclin D/Cdk4/6 complex assembly. Inhibition would theoretically increase the pool of free p27 (p27 can only bind to cyclin/Cdk complexes) thus permitting more p27 to bind and inhibit cyclin E/Cdk2 complexes. In support of this hypothesis, it has been recently reported that the inhibition of cyclin E/Cdk2 complexes by p27 is necessary for p16-induced cell cycle arrest (Jiang et al., 1998) . Another member of the INK family, p15, also displaces p27 from cyclin D/ Cdk4/6 complexes (ReynisdoÂ ttir and MassagueÂ , 1997). The expression of a dominant negative mutant of Cdk4 (Cdk4   N158   ) is not able to cause G1 arrest although it is able to inhibit cyclin D/Cdk4 activity as eectively as p16 overexpression (Jiang et al., 1998) . This Cdk4 mutant, however, is still able to form complexes with cyclin D which in turn can bind p27 and presumably sequester it away from cyclin E/Cdk2 complexes. Therefore, the total amount of p27 as well as the availability of cyclin D/Cdk4 complexes may in¯uence the ability of c-Myc to override p16-induced cell cycle arrest. However, in the absence of a signi®cant eect of c-Myc on cyclin D expression, it is not clear how cMyc in¯uences the assembly or availability of cyclin D/ Cdk4 complexes.
The relationship between c-Myc and Cdc25A
Beside the action of CKIs, cyclin/Cdk complexes are regulated by reversible phosphorylation (Morgan, 1995 (Morgan, , 1997 . Cdc25A belongs to a family of phosphatases that are important regulators of Cdk activity in dierent phases of the cell cycle (Homann et al., 1993 (Homann et al., , 1994 Jinno et al., 1994) . Activation of Cdc25 proteins occurs upon phosphorylation by cyclin/ Cdk complexes (Homann et al., 1993 (Homann et al., , 1994 . Cyclin E/Cdk2 phosphorylates Cdc25A at the G1/S transition, and the activity of Cdc25A is necessary for cyclin E/ Cdk2 activation, thus creating a positive feedback loop. The activity of Cdc25A is high from the G1/S boundary to mitosis, which suggests a role in the completion of the cell cycle (Homann et al., 1994) . Cdc25A has recently been proposed to be a target of cMyc transactivation (Galaktionov et al., 1996) . Therefore, perhaps it is the ability of c-Myc to induce Cdc25A which leads to the activation of cyclin E/Cdk2 complexes. However, following Myc-ER activation in quiescent cells, no changes in Cdc25A mRNA or protein were observed (PeÂ rez-Roger et al., 1997; Pusch et al., 1997) . In addition, if Cdc25A were responsible for c-Myc-induced cyclin E/Cdk2 activation, overexpression of Cdc25A would be expected to override a p27-imposed cell cycle arrest, which it does not (Vlach et al., 1996) . Furthermore, cdc25A gene expression was unaected in myc7/7 cells (Bush et al., 1998) . Therefore, it appears unlikely that Cdc25A is either a target of c-Myc, or part of the mechanism by which cyclin E/Cdk2 activation is induced by c-Myc.
Absence of c-Myc and the cell cycle
The recent isolation in our laboratory of established cell lines that are nullizygous for c-myc provide a new avenue for investigating the link between c-Myc and the cell cycle (Mateyak et al., 1997) . Both copies of the c-myc gene were eliminated by targeted homologous recombination in a Rat1 ®broblast cell line which does not express other Myc family members. Characterization of this cell line revealed that while c-Myc activity is not essential for survival, it is required for normal growth since c-myc7/7 cells proliferate at a rate approximately threefold slower than their wild-type counterparts. Analysis of the cell cycle distribution of exponentially growing c-myc7/7 cells demonstrated an increase in the length of both the G1 and G2 phases. A role for c-myc in G1 is supported by the work from many laboratories and has been discussed in detail above. Prior evidence for a role of c-Myc in G2 progression has been limited and indirect (Seth et al., 1996; Shibuya et al., 1992) . At present the role of cMyc in G2 remains unexplored, and further investigation in this area will certainly expand our understanding of the mechanisms by which c-Myc promotes cell cycle progression.
The initial characterization of cell cycle progression in c-myc7/7 cells complemented, at least in part, what has been learned from studies employing the Myc-ER construct. As described above, activation of Myc-ER in quiescent cells results in the premature activation of cyclin E/Cdk2 activity. Examination of Cdk2 activity in exponentially growing c-myc7/7 cells showed a marked decrease compared to myc+/+ cells. Furthermore, activation of cyclin E/Cdk2 kinase activity is both downregulated and delayed in myc7/7 cells undergoing the G0 to S phase transition (AJ Obaya and JM Sedivy, unpublished results). The myc7/7 cells provide an excellent model system in which to further investigate the mechanisms by which c-Myc in¯uences Cdk activity.
The area in which the analysis of c-myc7/7 cells has revealed new and surprising information relative to previous experiments with Myc-ER is the regulation of putative c-Myc target genes (Bush et al., 1998) . Activation of the Myc-ER protein results in a sustained upregulation of c-Myc activity, and has been widely used in conjunction with growth factor deprivation to identify c-Myc target genes. One drawback of this model is that c-Myc overexpression may lead to the misregulation of genes which are not physiological targets of c-Myc. Perhaps not surprisingly, it has been found that the expression of the majority of c-Myc target genes identi®ed to date is not aected by a c-myc knockout. The expression of only two putative c-Myc target genes is aected in c-myc7/7 cells: one c-Myc transactivated gene, cad, and one c-Myc repressed gene, gadd45 (Bush et al., 1998) . Neither of those genes have established roles in cell cycle regulation. Therefore, it is evident that additional c-Myc-regulated genes need to be discovered before we can understand how c-Myc interacts with the cell cycle.
An idea for the future
Characterization of c-myc7/7 cells prompted the hypothesis that c-Myc may control proliferation by aecting the rate of cellular mass accumulation (Mateyak et al., 1997) . This hypothesis is based on the observation that c-myc7/7 cells maintain the same volume, as well as total RNA and protein content, as c-myc+/+ cells while displaying global reductions in the rate of RNA and protein synthesis. The reduction of the overall rate of macromolecular synthesis is commensurate with the decrease in the rate of proliferation, and thus readily accounts for the fact that cell volume is not changed. The previous identi®cation of eIF-4E and LDH-A as putative cMyc target genes had also suggested that c-Myc may play a role in regulating cellular metabolism (Jones et al., 1996; Rosenwald et al., 1993b; Shim et al., 1997; Tavtigian et al., 1994) . However, the expression of neither of these genes is aected in c-myc7/7 cells (Bush et al., 1998) . More recently, c-Myc has been shown to upregulate the expression of the iron regulatory protein-2 (IRP2) and downregulate the expression of the heavy subunit of ferritin (Wu et al., 1999) . Thus, increased c-Myc activity would lead to increased intracellular concentrations of iron. The involvement of c-Myc in iron metabolism is an intriguing ®nding, and raises the possibility that cMyc may play a role in other iron-dependent metabolic processes, such as oxygen transport, mitochondrial energy metabolism and electron transport.
Several scenarios can be invoked to explain the potent eects of c-Myc on cellular proliferation. First, c-Myc may exert a primary eect on the cell cycle machinery, which in turn would lead to a slower rate of mass accumulation in response to the lengthening of the cell cycle. Alternatively, the primary eect of c-Myc may be on the rate of mass accumulation, or other basic metabolic processes, and the cell cycle machine may sense these perturbations and adjust itself to them. Finally, c-Myc may exert independent eects on cellular metabolism and cell cycle progression. The links between basic metabolic processes and the cell cycle machine are poorly understood, and further work will be required before we understand how c-Myc interfaces with these basic life processes. The crucial missing pieces to this puzzle are the identities of the genes that are regulated by the c-Myc transcription factor under both physiological and neoplastic conditions.
